TS News | Stock Alarm Pro

Atlas News Feed Alerts PortfolioEconomy Movers Regime Earnings Updates

TS(TS)

TS

Overview Fair Value Stream Notebook Intel Chart History Fundamentals TTM Earnings Analysts News Financials Segments Insiders Institl.DCF Peers

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Stock Alarm Pro

Real-time monitoring, screening, and research for professional investors and financial advisors.

support@stockalarm.io

Product

Screener
Chart Studio
Alerts
Institutional
Atlas

Company

About
For advisors
Blog
Press
Contact

© 2026 Stock Alarm, LLC, a product of Center Mark Capital, LLC. Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.

Home Screener Alerts

TS 3 articles

NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome

thenewswire.com·Jul 15

5 High-Flying Energy Stocks to Take Profits On

benzinga.com·May 4

Tenaris: The Picks-And-Shovels Play For An Oil Supply Crisis

forbes.com·Apr 24

Tenaris S.A.(TS)

$52.93—

Tenaris S.A.(TS)

NYSE

$52.93—